CD4 and head and neck cancer: On the other hand, several studies that focused on head and neck cancer did not find the abundant CD4 infiltrates to be associated with clinical outcomes (Balermpas et al., 2014; Distel et al., 2009; Nordfors et al., 2013; Wansom et al., 2012).